Desmoid tumour of the breast

被引:24
作者
Chummun, Shaheel [1 ]
McLean, Neil R. [2 ]
Abraham, S. [2 ]
Youseff, M. [2 ]
机构
[1] Frenchay Hosp, Dept Plast Surg, Bristol BS16 1LE, Avon, England
[2] Wansbeck Gen Hosp, Ashington, Northd, England
关键词
Desmoid tumour; Silicone implants; Breast augmentation; AGGRESSIVE FIBROMATOSIS; RADIATION-THERAPY; IMMUNOHISTOCHEMICAL ANALYSIS; ADENOMATOUS POLYPOSIS; SURGERY; MANAGEMENT; MUTATIONS; IMATINIB; GENE; MRI;
D O I
10.1016/j.bjps.2008.09.024
中图分类号
R61 [外科手术学];
学科分类号
摘要
Desmoid tumour of the breast is a rare fibroblastic tumour whose spectrum ranges from being locally inert to aggressive and destructive, and represents 0.2% of all breast tumours. A 22-year-old woman, 2 years post-cosmetic augmentation mammoplasty with silicone implants, presented with a 6-month history of an enlarging mass in her left breast. Ultrasound showed a well-defined, hypoechoic mass arising within the muscles of the anterior chest, deep beneath the implant and not involving the underlying rib. Fine needle aspiration (FNA) showed features in keeping with changes associated with silicone implants. A provisional diagnosis of scarring and fibroblastic proliferation was made. The lesion was excised and the implant, noted to be intact, was exchanged. Immunochemistry showed strong positivity for vimentin and variable positivity for SMA and desmin, and patchy positivity for beta catenin. A final diagnosis of aggressive fibromatosis was made. Although the association of desmoid tumour and breast implants has been described, this case is unique as the FNA was highly suggestive of a silicone granuloma and the diagnosis of desmoid tumour was made on definitive pathology. The aetiology of desmoid tumours is reviewed and current treatment modalities discussed. (C) 2008 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:339 / 345
页数:7
相关论文
共 81 条
[1]   Fibromatosis of the breast and mutations involving the APC/β-catenin pathway [J].
Abraham, SC ;
Reynolds, C ;
Lee, JH ;
Montgomery, EA ;
Baisden, BL ;
Krasinskas, AM ;
Wu, TT .
HUMAN PATHOLOGY, 2002, 33 (01) :39-46
[2]  
Alman BA, 1997, AM J PATHOL, V151, P329
[3]   Aggressive fibromatosis (desmoid tumor) is a monoclonal disorder [J].
Alman, BA ;
Pajerski, ME ;
DiazCano, S ;
Corboy, K ;
Wolfe, HJ .
DIAGNOSTIC MOLECULAR PATHOLOGY, 1997, 6 (02) :98-101
[4]  
Azzarelli A, 2001, CANCER, V92, P1259, DOI 10.1002/1097-0142(20010901)92:5<1259::AID-CNCR1446>3.0.CO
[5]  
2-Y
[6]   Desmoid tumor: Prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy [J].
Ballo, MT ;
Zagars, GK ;
Pollack, A ;
Pisters, PWT ;
Pollock, RA .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) :158-167
[7]  
Barber H M, 1973, J Bone Joint Surg Br, V55, P858
[8]  
Brennan MF, 2001, CANC PRINCIPLES PRAC, P1841
[9]   Deletion 5q in desmoid tumor and fluorescence in situ hybridization for chromosome 8 and/or 20 copy number [J].
Bridge, JA ;
Meloni, AM ;
Neff, JR ;
Deboer, J ;
Pickering, D ;
Dalence, C ;
Jeffrey, B ;
Sandberg, AA .
CANCER GENETICS AND CYTOGENETICS, 1996, 92 (02) :150-151
[10]   Genetic testing for germline mutations of the APC gene in patients with apparently sporadic desmoid tumors but a family history of colorectal carcinoma [J].
Brueckl, WM ;
Ballhausen, WG ;
Förtsch, T ;
Günther, K ;
Fiedler, W ;
Gentner, B ;
Croner, R ;
Boxberger, F ;
Kirchner, T ;
Hahn, EG ;
Hohenberger, W ;
Wein, A .
DISEASES OF THE COLON & RECTUM, 2005, 48 (06) :1275-1281